{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T21:58:20Z","timestamp":1781992700634,"version":"3.54.5"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To assess the association of tumor architecture with cancer recurrence, metastasis, and cancer-specific survival (CSS) in patients treated with radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC) in Taiwan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>Data were collected from 857 patients treated with RNU between January 2005 and August 2016 in our hospital. Pathologic slides were reviewed by genitourinary pathologists. Propensity score weighting was performed for data analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sessile growth pattern was observed in 212 patients (24.7%). Tumor architecture exhibited a significant association with bladder cancer history, chronic kidney disease (CKD), tumor stage, lymph node status, histological grade, lymphovascular invasion, concomitant carcinoma <jats:italic>in situ<\/jats:italic>, and the variant type [standardized mean difference (SMD) &amp;gt; 0.1 for all variables before weighting]. In the propensity score analysis, 424 papillary and sessile tumor architecture were analyzed to balance the baseline characteristics between the groups. Tumor architecture was an independent predictor of metastatic disease and CSS (p = 0.033 and p = 0.002, respectively). However, the associations of tumor architecture with bladder and contralateral recurrence were nonsignificant (p = 0.956 and p = 0.844, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Tumor architecture of UTUC after RNU is associated with established features of aggressive disease and predictors of metastasis and CSS. Assessment of tumor architecture may help identify patients who could benefit from close follow-up or early administration of systemic therapy after RNU. Tumor architecture should be included in UTUC staging after further confirmation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.613696","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T08:57:58Z","timestamp":1614243478000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The Prognostic Impact of Tumor Architecture for Upper Urinary Tract Urothelial Carcinoma: A Propensity Score-Weighted Analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Hui-Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Ta","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Tso","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih Hsiung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Ching","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chieh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Lun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chi","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao Lun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po Hui","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.2361","article-title":"Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma","volume":"27","author":"Kikuchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.08003.x","article-title":"Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients","volume":"103","author":"Remzi","year":"2009","journal-title":"BJU Int"},{"key":"B4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00345-011-0710-3","article-title":"Predictive factors of recurrence and survival of upper tract urothelial carcinomas","volume":"29","author":"Verhoest","year":"2011","journal-title":"World J Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2010.07.010","article-title":"Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma","volume":"30","author":"Fritsche","year":"2012","journal-title":"Urol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317710822","article-title":"Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"39","author":"Fan","year":"2017","journal-title":"Tumour Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00157","article-title":"Gender Is a Significant Prognostic Factor for Upper Tract Urothelial Carcinoma: A Large Hospital-Based Cancer Registry Study in an Endemic Area","volume":"9","author":"Huang","year":"2019","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10188.x","article-title":"Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study","volume":"108","author":"Matsumoto","year":"2011","journal-title":"BJU Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12238","article-title":"Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China","volume":"112","author":"Chen","year":"2013","journal-title":"BJU Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11691","article-title":"The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract","volume":"98","author":"Kang","year":"2003","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.01.054","article-title":"Significant Predictive Factors for Prognosis of Primary Upper Urinary Tract Cancer after Radical Nephroureterectomy in Taiwanese Patients","volume":"54","author":"Li","year":"2008","journal-title":"Eur Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.0.CO;2-B","article-title":"Unusual clinical presentation of upper urothelial carcinoma in Taiwan","volume":"85","author":"Chou","year":"1999","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01529-7","article-title":"Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan","volume":"59","author":"Yang","year":"2002","journal-title":"Urology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"B15","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs Lyon","year":"2004"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1827.2009.02477.x","article-title":"Non-invasive papillary urothelial neoplasms: the 2004 WHO\/ISUP classification system","volume":"60","author":"Miyamoto","year":"2010","journal-title":"Pathol Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12707","article-title":"Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy","volume":"115","author":"Ishioka","year":"2015","journal-title":"BJU Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-020-02048-7","article-title":"Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis","volume":"18","author":"Shao","year":"2020","journal-title":"World J Surg Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-006-0150-4","article-title":"Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract","volume":"448","author":"Langner","year":"2006","journal-title":"Virchows Arch"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.03.142","article-title":"Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract","volume":"184","author":"Margulis","year":"2010","journal-title":"J Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.10.158","article-title":"Prognostic Value of Extranodal Extension and Other Lymph Node Parameters in Patients With Upper Tract Urothelial Carcinoma","volume":"187","author":"Fajkovic","year":"2012","journal-title":"J Urol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1835-1","article-title":"Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study","volume":"35","author":"Favaretto","year":"2017","journal-title":"World J Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022176","article-title":"The prognostic value of tumor architecture in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A systematic review and meta-analysis","volume":"99","author":"Zhao","year":"2020","journal-title":"Med (Baltimore)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.613696\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T08:58:08Z","timestamp":1614243488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.613696\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":26,"alternative-id":["10.3389\/fonc.2021.613696"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.613696","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"article-number":"613696"}}